Cargando…
Rational Computational Approaches in Drug Discovery: Potential Inhibitors for Allosteric Regulation of Mutant Isocitrate Dehydrogenase-1 Enzyme in Cancers
Mutations in homodimeric isocitrate dehydrogenase (IDH) enzymes at specific arginine residues result in the abnormal activity to overproduce D-2 hydroxyglutarate (D-2HG), which is often projected as solid oncometabolite in cancers and other disorders. As a result, depicting the potential inhibitor f...
Autores principales: | Thamim, Masthan, Agrahari, Ashish Kumar, Gupta, Pawan, Thirumoorthy, Krishnan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005488/ https://www.ncbi.nlm.nih.gov/pubmed/36903561 http://dx.doi.org/10.3390/molecules28052315 |
Ejemplares similares
-
Structure and allosteric regulation of human NAD-dependent isocitrate dehydrogenase
por: Sun, Pengkai, et al.
Publicado: (2020) -
Mutant Isocitrate Dehydrogenase Inhibitors as Targeted Cancer Therapeutics
por: Golub, Danielle, et al.
Publicado: (2019) -
Assessing inhibitors of mutant isocitrate dehydrogenase using a suite of pre-clinical discovery assays
por: Urban, Daniel J., et al.
Publicado: (2017) -
Discovery of novel enasidenib analogues targeting inhibition of mutant isocitrate dehydrogenase 2 as antileukaemic agents
por: Khalil, Ahmed F., et al.
Publicado: (2023) -
Emerging Computational Methods for the Rational Discovery
of Allosteric Drugs
por: Wagner, Jeffrey R., et al.
Publicado: (2016)